Key Points
- CTO David Tsao sold 3,333 Billiontoone shares at an average of $125, generating $416,625; the transaction reduced his direct holdings by 76.92% to 1,000 shares. The sale was conducted under a pre-arranged Rule 10b5-1 plan.
- Billiontoone shares opened at $121.72, with a $5.74 billion market capitalization and a 12-month trading range of $61.96 to $150.44. The company recently met quarterly earnings expectations with $0.15 EPS and reported $109.45 million in revenue.
- Analyst sentiment is mixed but leans positive: seven analysts rate the stock Buy, two Hold, and two Sell, with an average price target of $125.88. Several firms recently lowered targets, while institutional investors increased their positions.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 1,416 shares of the stock in a transaction on Thursday, September 24th. The shares were sold at an average price of $120.00, for a total value of $169,920.00. Following the completion of the transaction, the senior vice president directly owned 22,219 shares in the company, valued at $2,666,280. This trade represents a 5.99% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $106.61, for a total value of $150,959.76.
- On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $97.54, for a total value of $138,116.64.
- On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $141,700.00.
- On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
Billiontoone Price Performance
BLLN stock opened at $121.72 on Tuesday. The business has a 50 day moving average price of $108.66 and a 200 day moving average price of $98.87. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The stock has a market cap of $5.74 billion and a price-to-earnings ratio of 173.89. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $150.44.
Billiontoone (NASDAQ:BLLN - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts' consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million for the quarter. Equities research analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts have commented on the stock. Guggenheim initiated coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a "buy" rating and a $125.00 price objective on the stock. Canaccord Genuity Group initiated coverage on Billiontoone in a report on Wednesday, September 2nd. They set a "buy" rating and a $120.00 price target for the company. Zacks Research lowered shares of Billiontoone from a "hold" rating to a "strong sell" rating in a research report on Monday, August 31st. BTIG Research cut their price objective on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a research report on Thursday, August 6th. Finally, Wall Street Zen cut shares of Billiontoone from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Seven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $125.88.
Read Our Latest Analysis on Billiontoone
Institutional Trading of Billiontoone
Several large investors have recently bought and sold shares of BLLN. Integrated Wealth Concepts LLC purchased a new position in shares of Billiontoone in the second quarter valued at $29,000. MCF Advisors LLC boosted its position in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock worth $54,000 after buying an additional 344 shares in the last quarter. Thrive Wealth Management LLC acquired a new stake in Billiontoone in the 2nd quarter valued at about $240,000. Caitong International Asset Management Co. Ltd purchased a new position in Billiontoone during the 4th quarter valued at about $230,000. Finally, Jasper Ridge Partners L.P. purchased a new position in Billiontoone during the 2nd quarter valued at about $615,000.
Billiontoone Company Profile
(
Get Free Report)
BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.
The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
